Ep 91: Beyond Metrics: Reimagining Success in Academic Medicine with Dr Anavekar
Ep 91: Beyond Metrics: Reimagining Success in Academic Medicine with Dr Anavekar

Average (ratings)
No ratings
 
  Your rating

In the second part of our mini-series exploring the concept of value in academic medicine, Dr Ankur Kalra once again engages in a compelling discussion with Dr Nandan Anavekar. Dr Anavekar, a Professor of Medicine at Mayo Clinic College of Medicine and consultant for both the Cardiovascular and Radiology Departments at Mayo Clinic, also serves as the Program Director for the Adult Cardiovascular Diseases Fellowship program.

 

In this stimulating and thought-provoking episode, Dr Kalra and Dr Anavekar delve into the topic of measuring success in medicine. Dr Anavekar puts forward the argument that the ambiguous definition of academic achievement often results in damaging biases that have long-term repercussions on the medical field. As a program director, Dr Anavekar believes that the number of published articles should not be the only or most crucial criterion for evaluating early-career faculty. He argues that it's important to also consider the "distance travelled" by candidates.

Dr Kalra raises pertinent questions about the practical implications of this approach, and Dr Anavekar provides candid insights into his responsibilities. The conversation also sheds light on the "publish or perish" mentality and highlights the need to prioritize patient needs over the ideals of the experts treating them.

 

Can we move beyond binary thinking when it comes to measuring success in medicine? How does Dr Anavekar tackle research questions? What is the true essence of being "academic"?

 

Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode.
Guest: @nandananavekar, host: @AnkurKalraMD and produced by: @RadcliffeCARDIO.


Read MoreRead Less
Share
Up Next
Ep 92: Beyond Metrics (Part 3): Redefining Success Through a Student-Centric Approach with Dr. Nandan Anavekar
EP92 • May 15, 2023 • 41m 36s
In this inspiring conversation, Dr Anavekar and Dr Kalra discuss the education of postgraduate medical students and reflect on Dr Anavekar’s role as a Program Director. Dr Anavekar shares his motivations and the moral framework he uses to approach his responsibility towards his students.
Read More
All Episodes
High-Sensitivity Cardiac Troponin ACS
EP02 • Apr 23, 2020 • 29m 55s
Ankur is back with his second #AudioArticle! This week he spoke with Santiago Garcia from the Minneapolis Heart Institute about Santiago’s US Cardiology Review 13.1 article on the role of high-sensitivity cardiac troponin (hscTn) assays and their ability to rapidly rule in or rule out acute coronary syndrome (ACS) with improved sensitivity.



Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER.



Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.
Read More
01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger
EP01 • Apr 23, 2020 • 27m 44s
In our first episode, Ankur explains his vision for and inspiration to start ‘Parallax’, and speaks with Chad Kliger from Lenox Hill Hospital in New York about conduction abnormalities after transcatheter aortic valve replacement (TAVR/TAVI), a review article published in US Cardiology Review 13.1 Ankur and Chad look at conduction abnormalities after TAVR/TAVI with a focus on basic conduction system anatomy in relation to the aortic valve, the mechanism, incidence, predisposing factors for occurrence, impact on mortality and finally, proposed treatment algorithms for management. Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.
Read More
EP 112: Just One Heart: Burnout, Positive Mindset & Leadership with Dr Fisher
EP112 • May 20, 2024 • 50m 25s
Tune in for a rich discussion with Dr Jonathan Fisher and Dr Ankur Kalra on the future of healthcare, well-being, and rediscovering the human connection at the heart of medicine. Find out more about the bestselling book Just One Heart: A Cardiologist’s Guide to Healing, Health, and Happiness.
Read More
EP 111: ACC 24 in Review With Dr Vallabhajosyula: 5 Trials That Will Change Your Practice
EP111 • Apr 22, 2024 • 1h 11m 26s
Dr Kalra and Dr Vallabhajosyula dissect the practical implications of the top 5 ACC.24 trials, answering pressing questions and addressing emerging dilemmas.
Read More
EP 110: Cultivating Leadership, Civic Duty & the Presidential Leadership Programme with Dr Sinha
EP110 • Apr 08, 2024 • 43m 28s
In this episode, Dr Sinha shares his insights on leadership after participating in the prestigious Presidential Leadership Scholars Programme.
Read More
EP 109: Navigating Volume Status in Heart Failure Patients with Dr Andrew Darlington
EP109 • Mar 11, 2024 • 38m 44s
In this informative episode of Parallax, Dr Ankur Kalra is joined by Dr Andrew Darlington, an Advanced Heart Failure Cardiologist at Piedmont Heart Institute in Georgia.

Together, Dr Kalra and Dr Darlington delve into the significance of assessing volume status in patients with heart failure, highlighting its continued relevance in 2024, including the availability of new diagnostic tools, including the Heart Failure Management System (HFMS).

This series is supported by ZOLL and is intended for Health Care Professionals.
Read More
EP 108: Song of Our Scars: Authorship & Medicine with Senior Advisor for FDA, Dr Warraich
EP108 • Feb 26, 2024 • 44m 44s
In this week's Parallax episode, Dr Ankur Kalra welcomes Dr Haider Warraich, a cardiologist at Brigham and Women's Hospital. Dr Warraich is not only a Senior Advisor for Chronic Disease to the FDA Commissioner but also a prolific author, having written three books, including "Song of Our Scars: The Untold Story of Pain." He is a regular contributor to publications like the New York Times and the Washington Post.
Read More